40 Hz Visual Stimulation as an Intervention in Schizophrenia

Recruiting N/A Interventional Study
Negative Symptoms in Schizophrenia Schizophrenia Disorders Schizoaffective Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
20 (estimated)
Sponsor
Technical University of Munich · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
In schizophrenia, an abnormal reduction in neuronal gamma oscillations (30-100 Hz) is associated with negative symptoms such as cognitive dysfunction. The literature suggests that rescuing gamma oscillations through non-invasive brain stimulation may be an accessible and safe add-on strategy to mitigate negative symptoms. Here, a stimulation protocol based on gamma visual stimulation will be teste…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Medical diagnosis of schizophrenia (F20) or schizoaffective disorder (F25) Exclusion Criteria: * Age \< 18 years * Any history of seizures * Acute suicidality assessed with the Columbia-Suicide Severity Rating Scale (C-SSRS; Brent et al., 2008) * Any other relevant axis 1 di…
Contacts

Ulrike Vogelmann, MD

+4917661535471

ulrike.vogelmann@mri.tum.de

CONTACT